The forecasted sold production of medicaments containing corticosteroid hormones in France shows a declining trend from 2024 to 2028, with values decreasing annually from 520.66 million euros to 463.16 million euros. In 2023, the production value stood at 535.2 million euros, indicating a consistent downward trajectory.

Year-on-year variations reveal a decrease of approximately 2.8% in 2025, 2.9% in 2026, 2.9% in 2027, and 3.0% in 2028. The compound annual growth rate (CAGR) over the five-year period from 2023 to 2028 is projected to be a decline of around 3.1%, highlighting a consistent reduction in market size.

Future trends to watch for:

Potential regulatory changes affecting corticosteroid medicament production and sales.
Developments in alternative treatments that might impact demand.
Technological advancements in pharmaceutical manufacturing processes.
Public health policies and population health trends affecting usage rates.